Combo Delivery Flashcards

1
Q

5 curative cancers

A
  1. Acute lymphocytic Leukemia (peds especially)
  2. some pediatric sarcomas
  3. germ cell tumors
  4. aggressive and intermediate lymphomas
  5. acute myeloid leukemia (in young)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mechanisms of chemo resistance?

A

Altered apoptosis threshold
Drug avoidance mechanisms
Toxicity to host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drug avoidance mechanisms

A
  1. down regulating transport mechanism
  2. upregulating drug efflux
  3. down regulating metabolic pathways
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Venetoclax action

A

Targets Bcl-2 to restore pro-apoptotic signals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Venetoclax

A

mimics BH3 domain which is a natural inhibitor of the anti-apoptotic Bcl-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does BH3 promote apoptosis

A

promotes cytochrome C release from mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why is Venetoclax so special?

A

rare to find small molecules that mimic protein-protein interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Venetoclax DLT?

A

so potent that is causes excessive tumor lysis syndrome if not given carefully.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antagonistic

A

1 + 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ineffective

A

1 + 1 = 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Additive

A

1 + 1 = 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Synergistic

A

1 + 1 > 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Curative

A

some fractions of patients will be cured.

curative intent - cures at least 5% of people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Control

A

Less than 5% chance of cure, provides reasonable chance of altering natural history of disease so patients will live longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Palliative

A

Alleviates symptoms or pre emptively addresses an issue that will reliably be morbid,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Textbook principles of combination chemo

A
  • use agents with different MOA

- Use agents with non-overlapping toxicity

17
Q

catch phrase for using agents of different mechanistic classes?

A

non-cross resistant

18
Q

Bleomycin

A

natural, made by streptomyces. induces DNA strand breaks.

19
Q

Bleomycin

A

little myelosuppression, doesn’t drive down WBC

20
Q

Bleomycin use

A

lymphoma

21
Q

Bleomycin warning

A

causes fatal pulmonary fibrosis. Risk higher in smokers and is prohibited in the presence of pulmonary hemorrhage or pulmonary embolism.

22
Q

BEP stands for…

A

Bleomycin, Etoposide, Cisplatin

23
Q

BEP uses

A

Germ cell tumors

24
Q

RCHOP stands for…

A

Rituximab, Cytoxan, Doxorubicin, Vincristine, Prednisone

25
Q

RCHOP uses

A

intermediate risk non-Hodgkin lymphoma (curative 80% of time)

26
Q

ABVD stands for…

A

Doxorubicin, Bleomycin, Vinblastine, Dacarbazine

27
Q

ABVD use

A

Hodgkins (90% cure)

28
Q

3 + 7

A

Daunorubicin, Ara-C

29
Q

3 + 7 use

A

AML

30
Q

AC - T

A

Doxorubicin, Cyclophosphamide, Taxane

31
Q

AC-T use

A

breast cancer

32
Q

4 delivery systems

A

Liposomes
Targeted Liposomes
Antibody drug conjugates
Drugs with polymers

33
Q

Liposomal Doxorubicin

A

Safer cardiac

More hand/foot syndrome

34
Q

Brentuximab Vedotin

A

Very active drug against CD-30 expressing lymphomas (most all Hodgkin lymphomas)
Built from an antibody and a highly toxic anti-tubule drug that is way too toxic to be used in non-targeted way

35
Q

Trastuzumab - Maytansine (T-DM1)

A

Important for Her2 expressing breast cancers

Highly toxic antitubule that is too toxic to be used in non targeted way